BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Earlier studies have clearly documented that in an already unstable genome as a result of BCR::ABL1 in CML, the emergence of ACAs might result in further genetic instability, aberrant cellular processes, and altered metabolism (25, 62, 63).